Postsynaptic antagonism by 4-aminopyridine of ketamine effect in frog (Hyla crepitans) neuromuscular junctions. 1991

E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
Department of Anesthesiology, Hospital de Clinicas Caracas, Venezuela.

The action of ketamine (50 microM) and 4-aminopyridine (4-AP) (50 microM) on the frog (Hyla crepitans) neuromuscular junction using standard intracellular recording techniques was investigated. In our experiments the amplitude of evoked end plate potential was decreased by ketamine and increased by 4-AP, which is similar to the effects reported by other investigators. However, novel effects of the drugs on postsynaptic acetylcholine receptors were detected when miniature end plate potential (MEPP) amplitude and time-course were analyzed. The experiments were performed and registered in presence of 1% dimethylsulfoxide to augment frequency of MEPP's. When ketamine was added to the saline solution, MEPP amplitude control values were reduced from 226 (214, 240) microV (n = 529, median and its 95% confidence interval) to 140 (130, 151) microV (n = 143) by 50 microM ketamine. 4-AP alone also depressed MEPP amplitude to 129 (70, 152) microV (n = 91). The two drugs are partial antagonists, when they were applied together, MEPP amplitude was 180 (172, 188) microV (n = 207). The effect of ketamine on time course of MEPP's, expressed as time to peak, reduced the control values of 4.74 (4.61, 4.88) msec (n = 529) to 3.84 (3.72, 4.01) msec (n = 143) (P less than 0.001); the effect of 4-AP was to reduce the control values to 1.93 (1.79, 2.10) msec (n = 91). The time to peak after adding ketamine and 4-AP was 3.25 (3.12, 3.38) msec (n = 207), expressing an antagonistic effect of the drugs. All values are statistically distinct (P less than 0.001). Thus, our results show that a postsynaptic mechanism is responsible for a significant part of the antagonism of ketamine effects by 4-AP.

UI MeSH Term Description Entries
D007649 Ketamine A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D009045 Motor Endplate The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors. Motor End-Plate,End-Plate, Motor,End-Plates, Motor,Endplate, Motor,Endplates, Motor,Motor End Plate,Motor End-Plates,Motor Endplates
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011898 Ranidae The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica. Frogs, True,Rana,Frog, True,True Frog,True Frogs
D005071 Evoked Potentials Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported. Event Related Potential,Event-Related Potentials,Evoked Potential,N100 Evoked Potential,P50 Evoked Potential,N1 Wave,N100 Evoked Potentials,N2 Wave,N200 Evoked Potentials,N3 Wave,N300 Evoked Potentials,N4 Wave,N400 Evoked Potentials,P2 Wave,P200 Evoked Potentials,P50 Evoked Potentials,P50 Wave,P600 Evoked Potentials,Potentials, Event-Related,Event Related Potentials,Event-Related Potential,Evoked Potential, N100,Evoked Potential, N200,Evoked Potential, N300,Evoked Potential, N400,Evoked Potential, P200,Evoked Potential, P50,Evoked Potential, P600,Evoked Potentials, N100,Evoked Potentials, N200,Evoked Potentials, N300,Evoked Potentials, N400,Evoked Potentials, P200,Evoked Potentials, P50,Evoked Potentials, P600,N1 Waves,N2 Waves,N200 Evoked Potential,N3 Waves,N300 Evoked Potential,N4 Waves,N400 Evoked Potential,P2 Waves,P200 Evoked Potential,P50 Waves,P600 Evoked Potential,Potential, Event Related,Potential, Event-Related,Potential, Evoked,Potentials, Event Related,Potentials, Evoked,Potentials, N400 Evoked,Related Potential, Event,Related Potentials, Event,Wave, N1,Wave, N2,Wave, N3,Wave, N4,Wave, P2,Wave, P50,Waves, N1,Waves, N2,Waves, N3,Waves, N4,Waves, P2,Waves, P50
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015761 4-Aminopyridine One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. 4-Aminopyridine Sustained Release,Dalfampridine,Fampridine-SR,Pymadine,VMI-103,4 Aminopyridine,4 Aminopyridine Sustained Release,Fampridine SR,Sustained Release, 4-Aminopyridine,VMI 103,VMI103

Related Publications

E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
February 1981, British journal of anaesthesia,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
January 1982, British journal of anaesthesia,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
April 1980, British journal of anaesthesia,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
March 1983, American journal of veterinary research,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
January 1980, Acta anaesthesiologica Belgica,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
May 1984, American journal of veterinary research,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
December 1977, The Journal of pharmacology and experimental therapeutics,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
November 1975, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
January 1980, Anesthesia and analgesia,
E Martínez-Aguirre, and J Rodríguez-Hernández, and C Sevcik
April 1991, American journal of veterinary research,
Copied contents to your clipboard!